Steffek
Amy Steffek, Birmingham, MI US
Patent application number | Description | Published |
---|---|---|
20130155066 | Method and system for visualizing a volume dataset - A machine-implemented display method that, with respect to a volume dataset being rendered, enables a user to navigate to any position in space and look in any direction. Preferably, the volume dataset is derived from a computer tomography (CT) or magnetic resonance imaging (MRI) scan. With the described approach, the user can see details within the dataset that are not available using conventional visualization approaches. The freedom-of-motion capability allows the user to go to places (positions) within the volume rendering that are not otherwise possible using conventional “orbit” and “zoom” display techniques. Thus, for example, using the described approach, the display image enables a user to travel inside physical structures (e.g., a patient's heart, brain, arteries, and the like). | 06-20-2013 |
Cory D. Steffek, Pittsburgh, PA US
Patent application number | Description | Published |
---|---|---|
20090123738 | SUBSTRATES COATED WITH A MULTI-FILM FUNCTIONAL COATING - The present invention is directed toward a coated substrate including an undercoating layer deposited on at least a portion of the substrate and a functional coating layer deposited over at least a portion of the undercoating layer. The functional coating layer comprises a material that can be present in more than one crystal structure. | 05-14-2009 |
Cory D. Steffek, Evanston, IL US
Patent application number | Description | Published |
---|---|---|
20080226819 | METHODS OF MAKING CRYSTALLINE TITANIA COATINGS - A method is provided for shifting the amorphous to crystalline transition temperature of a titania coating. The method includes adding a dopant, such as Mo, V, Al, Zn, Zr, Li, K, Co, La, Ca, Ba, Si, Ag, Cu, Ni, Mg, Mn, Cd, Fe, Cr, Tb, Y, Sn, Ge, and/or Pd to a titania-containing material. The doped material can then be applied, e.g., by spray pyrolysis, onto a substrate. A coated article is also provided. | 09-18-2008 |
20090056264 | RETAINER CLIP FOR GRID SIMULATING MUNTINS - A grid simulating muntins is retained or secured by clips within a spacer frame between glass sheets. The clips include a spacer-engaging member having a platform, and upright walls bendable toward one another, and a grid-engaging member. The grid-engaging member is mounted on the platform, extends upward between and spaced from the upright walls, and is received into one of the ends of the elongated members of the grid. The platform and portions of the upright walls of the spacer-engaging member are positioned within the spacer frame such that the ends of the elongated members of the grid are below the sight line of the unit. The spacer-engaging member and the grid-engaging member can be a monolithic piece, or the grid-engaging member can be detachably secured to the platform of the spacer-engaging member. | 03-05-2009 |
Micah Steffek, Walnut Creek, CA US
Patent application number | Description | Published |
---|---|---|
20100291694 | Crystal Structure of CRIg and C3B:CRIg Complex - The present invention concerns determination of the crystal structure of the macrophage specific receptor, CRIg (earlier referred to as STIgMA), and its complex with the C3b and C3c subunits of complement C3 (C3b:CRIg and C3c:CRIg complexes). The invention further concerns the use of the crystal structure of CRIg or the C3b:CRIg complex to screen for and identify molecules structurally and/or functionally related to CRIg, including CRIg agonists and antagonists. | 11-18-2010 |
20130302333 | PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS - The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration of Factor D antagonists. | 11-14-2013 |
Micah Steffek, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20110282034 | PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS - The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration of Factor D antagonists. | 11-17-2011 |